• LAST PRICE
    5.5400
  • TODAY'S CHANGE (%)
    Trending Up0.0800 (1.4652%)
  • Bid / Lots
    5.2600/ 10
  • Ask / Lots
    5.7300/ 20
  • Open / Previous Close
    5.5900 / 5.4600
  • Day Range
    Low 5.3300
    High 5.6300
  • 52 Week Range
    Low 3.6100
    High 23.0300
  • Volume
    315,166
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Thursday's close: 5.46
TimeVolumeBMEA
09:32 ET30185.465
09:36 ET10005.52
09:38 ET4005.56
09:41 ET14005.59
09:43 ET5005.62
09:45 ET95535.63
09:48 ET1365.62
09:50 ET1005.62
09:52 ET13005.59
09:54 ET7005.5803
09:56 ET27395.61
09:57 ET27675.5703
09:59 ET16005.535
10:01 ET8115.5
10:03 ET13005.5106
10:06 ET6805.53
10:08 ET72005.52
10:10 ET8005.49
10:14 ET24925.4986
10:17 ET14005.4602
10:19 ET4005.45
10:21 ET6065.42
10:26 ET5275.44
10:28 ET7635.44
10:30 ET2125.43
10:32 ET13535.4
10:33 ET8825.41
10:35 ET7005.43
10:37 ET1005.43
10:39 ET10095.44
10:42 ET17005.43
10:44 ET1005.44
10:46 ET1005.43
10:48 ET28005.43
10:50 ET9825.45
10:51 ET24275.41
10:53 ET1005.41
10:55 ET4005.42
10:57 ET4005.43
11:00 ET2005.44
11:02 ET40095.4
11:04 ET2485.4
11:06 ET7005.38
11:08 ET45255.3599
11:09 ET24375.37
11:11 ET17005.37
11:13 ET2005.36
11:15 ET5285.35
11:18 ET71925.39
11:22 ET1005.375
11:24 ET1005.39
11:26 ET2005.4
11:29 ET1005.42
11:36 ET5005.4178
11:40 ET12175.43
11:42 ET4785.43
11:44 ET1135.43
11:45 ET5005.43
11:47 ET4675.42
11:51 ET5005.4199
11:54 ET1005.42
11:56 ET6845.41
12:00 ET6005.43
12:02 ET5695.43
12:05 ET3635.43
12:07 ET6655.45
12:09 ET3665.4488
12:12 ET10275.43
12:14 ET44985.45
12:16 ET16745.475
12:23 ET11845.465
12:25 ET8005.48
12:27 ET2005.5
12:30 ET1655.5
12:32 ET22745.51
12:34 ET7375.4979
12:36 ET21005.465
12:38 ET2125.46
12:41 ET4505.448
12:43 ET17205.45
12:56 ET483145.41
12:57 ET35705.39
12:59 ET8995.41
01:01 ET16525.435
01:03 ET5005.422
01:06 ET2075.44
01:08 ET1005.45
01:10 ET1005.44
01:12 ET6005.43
01:14 ET8005.43
01:17 ET1005.43
01:21 ET8555.47
01:24 ET5005.4475
01:28 ET2785.45
01:30 ET7005.49
01:33 ET4995.49
01:35 ET16215.425
01:37 ET3005.45
01:42 ET2855.45
01:46 ET3545.4844
01:48 ET3005.49
01:51 ET1005.485
02:00 ET7335.5
02:02 ET6215.51
02:06 ET11765.49
02:08 ET4635.4999
02:09 ET6555.51
02:11 ET52735.52
02:13 ET21375.54
02:20 ET1005.52
02:24 ET2005.51
02:26 ET3435.51
02:31 ET2005.51
02:33 ET20195.51
02:36 ET4445.5
02:38 ET1995.4918
02:40 ET4865.5
02:42 ET44235.48
02:44 ET1005.48
02:45 ET2005.48
02:47 ET2095.48
02:49 ET1005.48
02:51 ET5515.49
02:54 ET3005.52
02:56 ET1005.51
02:58 ET2205.52
03:02 ET1005.5
03:03 ET13975.5
03:05 ET2005.49
03:07 ET2005.5
03:09 ET1005.51
03:14 ET4795.52
03:16 ET2945.52
03:20 ET3855.52
03:21 ET1005.525
03:23 ET1005.525
03:25 ET5005.53
03:27 ET15135.525
03:30 ET2005.525
03:32 ET14925.505
03:34 ET20555.5
03:36 ET5655.51
03:38 ET2005.52
03:39 ET7365.535
03:41 ET2005.53
03:43 ET6515.53
03:45 ET5745.525
03:48 ET5005.53
03:50 ET25475.53
03:52 ET17285.54
03:54 ET19635.535
03:56 ET38385.53
03:57 ET10365.53
03:59 ET394825.54
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesBMEA
Biomea Fusion Inc
196.3M
-1.6x
---
United StatesOTLK
Outlook Therapeutics Inc
195.2M
-0.7x
---
United StatesCADL
Candel Therapeutics Inc
193.7M
-5.2x
---
United StatesGUTS
Fractyl Health Inc
193.5M
-2.4x
---
United StatesVTYX
Ventyx Biosciences Inc
204.4M
-0.9x
---
United StatesABOS
Acumen Pharmaceuticals Inc
204.9M
-3.3x
---
As of 2024-07-26

Company Information

Biomea Fusion, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the discovery and development of oral covalent small molecules to treat patients with metabolic diseases and genetically defined cancers. A covalent small molecule is a synthetic compound that forms a permanent bond to its target protein. The Company is utilizing its proprietary FUSION System to discover, design and develop a pipeline of covalent-binding small molecule medicines designed to maximize clinical benefit for patients. Its lead product candidate, BMF-219, is designed to be an oral, potent, and selective covalent inhibitor of menin, built from its FUSION System. It is developing BMF-219 for the treatment of menin regulated or dependent diseases, such as type 1 and type 2 diabetes as well as subtypes of liquid and solid tumors. Its second development candidate, BMF-500, a covalent inhibitor of activating mutations of the FMS-like tyrosine kinase 3 (FLT3).

Contact Information

Headquarters
900 Middlefield Road, 4Th FloorREDWOOD CITY, CA, United States 94063
Phone
650-980-9099
Fax
302-655-5049

Executives

Chairman of the Board, Chief Executive Officer, Co-Founder
Thomas Butler
President, Co-Founder, Chief Operating Officer, Director
Rainer Erdtmann
Chief Financial Officer
Franco Valle
Chief Medical Officer
Juan Fras
Independent Director
Eric Aguiar

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$196.3M
Revenue (TTM)
$0.00
Shares Outstanding
35.9M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
---
EPS
$-3.57
Book Value
$4.72
P/E Ratio
-1.6x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.